Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9

Product Details
Customization: Available
State: Powder
Extract Source: Rhododendron
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Years of Export Experience
The export experience of the supplier is more than 10 years
Full Customization
The supplier provides full customization services
R&D Capabilities
The supplier has 1 R&D engineers, you can check the Audit Report for more information
to see all verified strength labels (11)
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
  • Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9
Find Similar Products
  • Overview
  • About this item
  • About us
Overview

Basic Info.

Model NO.
NY040
Lead Time
5 Days
Transport Package
25kg/Drum
Specification
98%
Trademark
Nutrayours/ OEM
Origin
China
HS Code
1302199099
Production Capacity
3000kg/Year

Product Description

 

About this item

  • 100% NATURAL PRODUCT: No artificial colors or flavors
  • Verified herb identity, confirmed highest quality of raw herb and the extract
  • Best natural sources of herbs and raw materials: Every vendor is carefully picked to meet our high standards
  • Third-party lab tested, pure Azelaic Acid
       Antibacterial actionIt can inhibit and kill all kinds of oxygen-requiring bacteria and anaerobic bacteria on the skin
Anti-inflammatory effect Products that inhibit reactive oxygen species and thus play an anti-inflammatory role;
Reduce oil production It can inhibit the action of 5-a reductase, thus inhibiting the secretion of skin oil
Prevent skin keratosis It has an anti-keratinizing effect on normal skin and acne-infected skin to prevent hyperkeratosis of hair follicles Pigment specific It can inhibit tyrosinase and reduce melanin because it is used to treat melasma and post-inflammatory pigmentation.

 
Azelaic acid is a kind of skin disease prevention and treatment  mainly used to treat acne, chloasma and skin melanin deposition.  It is also an important organic synthesis intermediate, used in plastics, rubber and other industries to synthesize plasticizer, used in aviation oil for synthesis of low temperature and high speed lubricating oil, electrolytic capacitor manufacturing and other aspects of important applications.  The preparation of azelaic acid from unsaturated fatty acids such as oleic acid and corresponding triglycerides such as castor oil and cottonseed oil is the main production method at present.  
Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9




 
Items Standard Results  
Appeaeance White powder solid Qualified
Content 99.00% 99.42%
Total dicarboxylic acid content 99.5% 99.57%
Monoacid content 0.10% 0.08%
Melting point 107.5ºC-108.5ºC 107.6ºC-108.2ºC
Acid value 585.0mgKOH/g-595.0mgKOH/g 593.7mgKOH/g
Water content 0.5% 0.39%
Ash content 0.05% 0.02%
Heavy metal 0.001% 0.0008%
Light transmittance,440nm 97%-100% 98%
Light transmittance,550nm 97%-100% 98%
Partide size 50um 98.0%<50um
30%<30um
The chloride ion 0.005% 0.003%
Sulfate 0.025% 0.020%
Iron ions 0.002% 0.0019%
 

About us

Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9Azelaic Acid Powder 99% Azelaic Acid CAS 123-99-9* The statements in this section have not been evaluated by the FDA or EFSA.

References




1.Liu H, Yu H, Xia J, Liu L, Liu GJ, Sang H, Peinemann F.Cochrane Database Syst Rev. 2020 May 1;5(5):CD011368. doi: 10.1002/14651858.CD011368.pub2.PMID: 32356369 
2.Todea A, Deganutti C, Spennato M, Asaro F, Zingone G, Milizia T, Gardossi L.Polymers (Basel). 2021 Nov 24;13(23):4091. doi: 10.3390/polym13234091.PMID: 34883592
3.Nazzaro-Porro M.J Am Acad Dermatol. 1987 Dec;17(6):1033-41. doi: 10.1016/s0190-9622(87)70294-1.PMID: 2963038 

4.King S, Campbell J, Rowe R, Daly ML, Moncrieff G, Maybury C.J Cosmet Dermatol. 2023 Oct;22(10):2650-2662. doi: 10.1111/jocd.15923. Epub 2023 Aug 7.PMID: 37550898 
5.Chilicka K, Rogowska AM, Szyguła R, Dzieńdziora-Urbińska I, Taradaj J.Sci Rep. 2020 Jul 28;10(1):12612. doi: 10.1038/s41598-020-69530-w.PMID: 32724156 

 

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier